A preparative route to fused indeno[1,2-e][1,2,4]-triazolo[4,3- a]pyrazin-4-ones

Heterocycles

Volumn 51, Issue 12, 1999, Pages 2977-2982

  Ribeill, Yves ^a   Genevois Borella, Arielle ^a   Vuilhorgne, Marc ^a   Mignani, Serge ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR; INDENO[1,2 E][1,2,4]TRIAZOLO[4,3 A]PYRAZIN 4 ONE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID; PYRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; DEGENERATIVE DISEASE; DRUG STRUCTURE; DRUG SYNTHESIS; NERVE CELL DEGENERATION; NEUROPROTECTION;

EID: 0033373376     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-99-8682     Document Type: Article

References (24)

1. a) M. J. Croucher, J. F. Collins, and B. S. Meldrum, Science, 1982, 216, 899
2. b) D. W. Choi, Neuron, 1988, 1, 623
3. c) A. B. Yong, J. T. Greenamyre, Z. Hollingsworth, R. Albin, R. C. D'Amato, I. Shoulson, and J. B. Penney, Science, 1988, 241, 981
4. c) G. L. Collingridge and W. Singer, TIPS, 1990, 11, 290
5. d) J. W. Olney, Psychiatry, 1989, 3290
6. e) C. F. Bigge and S. S. Nikam, Exp. Opin. Ther. Patents, 1997, 7, 1099, and references cited therein.
7. H. F. Bradford, Progress in Neurobiology, 1995, 47, 477, and references cited therein.
8. S. Mignani, J-C. Aloup, J-C. Blanchard, G. A. Böhme, A. Boireau, D. Damour, M-W. Debono, M-C. Dubroeucq, A. Genevois-Borella, A. Imperato, P. Jimonet, J. Pratt, J. C. R. Randle, M. Reibaud, Y. Ribeill, and J-M. Stutzmann, Drug Dev. Res., 1999, in press.
9. For representative examples, see : a) K. Yamakawa and Y. Ishii, Japan Patent Application, JP 04191736 (Chem. Abstr., 1992, 117, 725)
10. b) B. Kobe, J. Kobe, D. F. Smee, B. Jerman-Blazic-Dzonova, and T. Solmajer, Eur. J. Med. Chem., 1992, 27, 259
11. c) Y-I. Lin, T. L. Fields, and S. A. Lang, J. Heterocycl. Chem., 1978, 15, 311
12. d) G. Doukhan, D. T. Huynh, E. Bisagni, J-C. Chermann, and J. Igolen, Eur. J. Med. Chem., 1979, 14, 375.
13. For representative examples, see : a) J. Ohmori, M. S. Sasamata, M. Okada, and S. Sakamoto, J. Med. Chem., 1997, 40, 2053
14. b) F. E. Nielsen, Patent Application, WO 9608493 (Chem. Abstr., 1996, 125, 1182)
15. c) B. Loev, J. H. Musser, R. E. Brown, H. Jones, R. Kahen, C. Huang, A. Khandwala, P. Sonnino-Goldman, and M. J. Leibowitz, J. Med. Chem., 1985, 28, 363.
16. N. Hoefgen, T. Buechner, U. Achterrath-Tuckermann, S. Szelenyi, and B. Kutscher, German Patent Application DE 19510965 (Chem. Abstr., 1996, 125, 1268)
17. G. Ferrand, H. Dumas, J-C. Depin, and N. Luong Trong, French Patent Application FR 2662163 (Chem. Abstr., 1992, 116, 751).
18. J-C. Aloup, F. Audiau, M. Barreau, D. Damour, A. Genevois-Borella, P. Jimonet, S. Mignani, and Y. Ribeill, Patent Application WO 9526351 (Chem. Abstr., 1996, 124, 1268).
19. T. Okamoto, K. Kobayashi, S. Oka, and S. Tanimoto, J. Org. Chem., 1988, 53, 4897.
20. P. W. Neber, A. Burgad, and W. Thier, Ann., 1936, 526, 277.
21. See for examples : ref. 5 and K. Makino, G. Sakata, and K. Morimoto, Heterocycles, 1985, 23, 2025.
22. For a similar cyclization reaction using chloramine T for the preparation of triazolo[4,3-a]pyridines and triazolo[4,3-b]pyridazines see : P. Bourgeois, R. Cantegril, A. Chêne, J. Gelin, J. Mortier, and J. Moyroud, Synth. Commun., 1993, 23, 3195.
23. See for example : T. Ramalingam, M. S. R. Murty, Y. V. D. Nageswara, and P. B. Sattur, J. Heterocyl. Chem., 1990, 27, 981.
24. 50's from 0.16 to 0.7 μM.